Clinical and Experimental Vaccine Research

The Korean Vaccine Society (대한백신학회)
권호 표지
DOI QR코드

DOI QR Code

Acute abdomen following COVID-19 vaccination: a systematic review

  • Nelson Luis Cahuapaza-Gutierrez (Facultad de Ciencias de la Salud, Carrera de Medicina Humana, Universidad Científica del Sur) ;
  • Renzo Pajuelo-Vasquez (Facultad de Ciencias de la Salud, Carrera de Medicina Humana, Universidad Científica del Sur) ;
  • Cristina Quiroz-Narvaez (Facultad de Ciencias de la Salud, Carrera de Medicina Humana, Universidad Científica del Sur) ;
  • Flavia Rioja-Torres (Facultad de Ciencias de la Salud, Carrera de Medicina Humana, Universidad Científica del Sur) ;
  • Maria Quispe-Andahua (Facultad de Ciencias de la Salud, Carrera de Medicina Humana, Universidad Científica del Sur) ;
  • Fernando M. Runzer-Colmenares (Facultad de Ciencias de la Salud, Carrera de Medicina Humana, Universidad Científica del Sur)
  • Received : 2023.10.11
  • Accepted : 2023.12.21
  • Published : 2024.01.31
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Conduct a systematic review of case reports and case series regarding the development of acute abdomen following coronavirus disease 2019 (COVID-19) vaccination, to describe the possible association and the clinical and demographic characteristics in detail. Materials and Methods: This study included case report studies and case series that focused on the development of acute abdomen following COVID-19 vaccination. Systematic review studies, literature, letters to the editor, brief comments, and so forth were excluded. PubMed, Scopus, EMBASE, and Web of Science databases were searched until June 15, 2023. The Joanna Briggs Institute tool was used to assess the risk of bias and the quality of the study. Descriptive data were presented as frequency, median, mean, and standard deviation. Results: Seventeen clinical case studies were identified, evaluating 17 patients with acute abdomen associated with COVID-19 vaccination, which included acute appendicitis (n=3), acute pancreatitis (n=9), diverticulitis (n=1), cholecystitis (n=2), and colitis (n=2). The COVID-19 vaccine most commonly linked to acute abdomen was Pfizer-BioNTech (messenger RNA), accounting for 64.71% of cases. Acute abdomen predominantly occurred after the first vaccine dose (52.94%). All patients responded objectively to medical (88.34%) and surgical (11.76%) treatment and were discharged within a few weeks. No cases of death were reported. Conclusion: Acute abdomen is a rare complication of great interest in the medical and surgical practice of COVID-19 vaccination. Our study is based on a small sample of patients; therefore, it is recommended to conduct future observational studies to fully elucidate the underlying mechanisms of this association.

Keywords

References

  1. Triggle CR, Bansal D, Ding H, et al. A comprehensive review of viral characteristics, transmission, pathophysiology, immune response, and management of SARS-CoV-2 and COVID-19 as a basis for controlling the pandemic. Front Immunol 2021;12:631139.
  2. World Health Organization. WHO coronavirus (COVID-19) dashboard [Internet]. Geneva: World Health Organization; 2023 [cited 2023 Apr 3]. Available from: https://covid19.who.int
  3. Marschner CA, Shaw KE, Tijmes FS, et al. Myocarditis following COVID-19 vaccination. Cardiol Clin 2022;40:375-88.
  4. Sharif N, Alzahrani KJ, Ahmed SN, Dey SK. Efficacy, immunogenicity and safety of COVID-19 vaccines: a systematic review and meta-analysis. Front Immunol 2021;12:714170.
  5. Fang E, Liu X, Li M, et al. Advances in COVID-19 mRNA vaccine development. Signal Transduct Target Ther 2022;7:94.
  6. Marco JJ, Pasquin MJ, Martin SM. Effectiveness and safety of currently available SARS-CoV-2 vaccines. FMC 2021;28:442-51.
  7. Ogunjimi OB, Tsalamandris G, Paladini A, Varrassi G, Zis P. Guillain-Barre syndrome induced by vaccination against COVID-19: a systematic review and meta-analysis.Cureus 2023;15:e37578.
  8. Paknahad MH, Yancheshmeh FB, Soleimani A. Cardiovascular complications of COVID-19 vaccines: a review of case-report and case-series studies. Heart Lung 2023;59:173-80.
  9. Li M, Wang X, Feng J, Feng Z, Li W, Ya B. Myocarditis or pericarditis following the COVID-19 vaccination in adolescents: a systematic review.Vaccines (Basel) 2022;10:1316.
  10. Jafarzadeh A, Jafarzadeh S, Pardehshenas M, Nemati M, Mortazavi SM. Development and exacerbation of autoimmune hemolytic anemia following COVID-19 vaccination: a systematic review. Int J Lab Hematol 2023;45:145-55.
  11. Lee YK, Huang YH. Ocular manifestations after receiving COVID-19 vaccine: a systematic review. Vaccines (Basel) 2021;9:1404.
  12. Pezzaioli LC, Gatta E, Bambini F, et al. Endocrine system after 2 years of COVID-19 vaccines: a narrative review of the literature. FrontEndocrinol(Lausanne) 2022;13:1027047.
  13. Oganesyan A, Schafer M, Lesh C. Acute appendicitis following the COVID-19 vaccine. J Surg Case Rep 2022;2022:rjac295.
  14. Cacdac R, Jamali A, Jamali R, Nemovi K, Vosoughi K, Bayraktutar Z. Acute pancreatitis as an adverse effect of COVID-19 vaccination. SAGEOpenMedCaseRep 2022;10:2050313X221131169.
  15. Ajmera K, Bansal R, Wilkinson H, Goyal L. Gastrointestinal complications of COVID-19 vaccines. Cureus 2022;14:e24070.
  16. Wahlen BM, Peralta R, Al-Thani H, El-Menyar A. Friend or foe: the Pfizer-BioNTech (BNT162b2) vaccination: a case report of reversible acute acalculous cholecystitis. Clin Case Rep 2022;10:e6078.
  17. Cui MH, Hou XL, Liu JY. Ischemic colitis after receiving the second dose of a COVID-19 inactivated vaccine: a case report. World J Clin Cases 2022;10:3866-71.
  18. Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.BMJ 2021;372:n71.
  19. Murad MH, Sultan S, Haffar S, Bazerbachi F. Methodological quality and synthesis of case series and case reports. BMJ Evid Based Med 2018;23:60-3.
  20. Ma LL, Wang YY, Yang ZH, Huang D, Weng H, Zeng XT. Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better? Mil Med Res 2020;7:7.
  21. Marconi E, Crescioli G, Bonaiuti R, et al. Acute appendicitis in a patient immunised with COVID-19 vaccine: a case report with morphological analysis. Br J Clin Pharmacol 2023;89:551-5.
  22. Kawano H, Yamamoto N, Kurohama H, et al. Fulminant myocarditis and acute appendicitis after COVID-19 vaccination.Intern Med 2023;62:411-7.
  23. Cieslewicz A, Dudek M, Krela-Kazmierczak I, Jablecka A, Lesiak M, Korzeniowska K. Pancreatic injury after COVID-19 vaccine: a case report. Vaccines (Basel) 2021;9:576.
  24. Parkash O, Sharko A, Farooqi A, Ying GW, Sura P. Acute pancreatitis: a possible side effect of COVID-19 vaccine. Cureus 2021;13:e14741.
  25. Dey RK, Ilango H, Bhatta S, et al. Acute pancreatitis in pregnancy following COVID-19 vaccine: a case report. J Med Case Rep 2022;16:354.
  26. Ozaka S, Kodera T, Ariki S, Kobayashi T, Murakami K. Acute pancreatitis soon after COVID-19 vaccination: a case report. Medicine (Baltimore) 2022;101:e28471.
  27. Alrashdi MN, Saleh AM, Khalid A, Alshaya AK, Alanazi SM. Systemic lupus erythematosus with acute pancreatitis and vasculitic rash following COVID-19 vaccine: a case report and literature review. Clin Rheumatol 2022;41:1577-82.
  28. Boskabadi SJ, Ala S, Heydari F, Ebrahimi M, Jamnani AN. Acute pancreatitis following COVID-19 vaccine: a case report and brief literature review. Heliyon 2023;9:e12914.
  29. Bangolo AI, Akhter M, Auda A, et al. A case report of acute severe necrotizing pancreatitis following the Johnson & Johnson vaccine against the Novel SARS-CoV-2. Case Rep Infect Dis 2023;2023:9965435.
  30. Stollberger C, Kastrati K, Dejaco C, et al. Necrotizing pancreatitis, microangiopathic hemolytic anemia and thrombocytopenia following the second dose of Pfizer/BioNTech COVID-19 mRNA vaccine. Wien Klin Wochenschr 2023;135:436-40.
  31. Kyungu FM, Katumba AM, Kamwira HL, et al. Acute acalculous cholecystitis following COVID-19 vaccination: a case report. Pan Afr Med J 2022;41:291.
  32. Vadioaloo SY, Zahidi MM, Tan PO. A case of eosinophilic colitis after BNT162b2 mRNA COVID-19 vaccination. J Interdiscip Med 2022;7:44-6.
  33. Moola S, Munn Z, Tufanaru C, et al. Systematic reviews of etiology and risk. In: Aromataris E, Munn Z, editors. JBI manual for evidence synthesis. Brisbane: The Joanna Briggs Institute; 2017. Chapter 7.
  34. Teoule P, Laffolie J, Rolle U, Reissfelder C. Acute appendicitis in childhood and adulthood. Dtsch Arztebl Int 2020;117:764-74.
  35. Ramson DM, Gao H, Penny-Dimri JC, et al. Duration of post-operative antibiotic treatment in acute complicated appendicitis: systematic review and meta-analysis. ANZ J Surg 2021;91:1397-404.
  36. Krzyzak M, Mulrooney SM. Acute appendicitis review: background, epidemiology, diagnosis, and treatment. Cureus 2020;12:e8562.
  37. Shahmoradi MK, Zarei F, Beiranvand M, Hosseinnia Z. A retrospective descriptive study based on etiology of appendicitis among patients undergoing appendectomy. Int J Surg Open 2021;31:100326.
  38. Barda N, Dagan N, Ben-Shlomo Y, et al. Safety of the BNT162b2 mRNA COVID-19 vaccine in a nationwide setting. N Engl J Med 2021;385:1078-90.
  39. Ljung R, Pihlstrom N, Sundstrom A. Risk of appendicitis after SARS-CoV-2 infection and SARS-CoV-2 vaccination. BrJ Surg 2022;109:775-6.
  40. Quint E, Kukeev I, Hazan I, et al. Clinical characteristics of SARS-CoV-2 vaccine-related acute appendicitis. Can J Surg 2023;66:E304-9.
  41. Mitchell J, Yue QY. Appendicitis as a possible safety signal forthe COVID-19 vaccines. Vaccine X 2021;9:100122.
  42. Muhammad Yusoff F, Wong KK, Mohd Redzwan N. Th1, Th2, and Th17 cytokines in systemic lupus erythematosus. Autoimmunity 2020;53:8-20.
  43. Ruber M, Berg A, Ekerfelt C, Olaison G, Andersson RE. Different cytokine profiles in patients with a history of gangrenous or phlegmonous appendicitis. Clin Exp Immunol 2006;143:117-24.
  44. Lee PJ, Papachristou GI. New insights into acute pancreatitis. Nat Rev Gastroenterol Hepatol 2019;16:479-96.
  45. Boxhoorn L, Voermans RP, Bouwense SA, et al. Acute pancreatitis. Lancet 2020;396:726-34.
  46. Das A, Chang D, Biankin AV, Merrett ND. Pancreatitis following human papillomavirus vaccination. Med J Aust 2008;189:178.
  47. Bizjak M, Bruck O, Praprotnik S, Dahan S, Shoenfeld Y. Pancreatitis after human papillomavirus vaccination: a matter of molecular mimicry.Immunol Res 2017;65:164-7.
  48. Shlomovitz E, Davies W, Cairns E, Brintnell WC, Goldszmidt M, Dresser GK. Severe necrotizing pancreatitis following combined hepatitis A and B vaccination. CMAJ 2007;176:339-42.
  49. Haviv YS, Sharkia M, Galun E, Safadi R. Pancreatitis following hepatitis A vaccination. Eur J Med Res 2000;5:229-30.
  50. Hansen LF, Nordling MM, Mortensen HB. Acute pancreatitis associated with MMR vaccination. Ugeskr Laeger 2003;165:2305-6.
  51. Toovey S, Jamieson A. Pancreatitis complicating adult immunisation with a combined mumps measles rubella vaccine: a case report and literature review. Travel Med Infect Dis 2003;1:189-92.
  52. Chan PW, Goh AY. Life threatening pancreatitis following varicella vaccination: cause, association or co-incidence? Med J Malaysia 2000;55:527-8.
  53. Gatt DT. Pancreatitis following monovalent typhoid and cholera vaccinations. BrJ Clin Pract 1986;40:300-1.
  54. Anand P, Puranik A, Aravamudan M, Venkatakrishnan AJ, Soundararajan V. SARS-CoV-2 strategically mimics proteolytic activation of human ENaC. Elife 2020;9:e58603.
  55. Ellison DL. Acute diverticulitis management. Crit Care Nurs Clin North Am 2018;30:67-74.
  56. Strate LL, Morris AM. Epidemiology, pathophysiology, and treatment of diverticulitis. Gastroenterology 2019;156:1282-98.
  57. Schieffer KM, Kline BP, Yochum GS, Koltun WA. Pathophysiology of diverticular disease. Expert Rev Gastroenterol Hepatol 2018;12:683-92.
  58. GallaherJR,CharlesA.Acute cholecystitis: a review.JAMA 2022;327:965-75.
  59. Kimura Y, Takada T, Strasberg SM, et al. TG13 current terminology, etiology, and epidemiology of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci 2013;20:8-23.
  60. Fu Y, Pang L, Dai W, Wu S, Kong J. Advances in the study of acute acalculous cholecystitis: a comprehensive review. Dig Dis 2022;40:468-78.
  61. Impellizzeri G, Marasco G, Eusebi LH, Salfi N, Bazzoli F, Zagari RM. Eosinophilic colitis: a clinicalreview. Dig Liver Dis 2019;51:769-73.
  62. Giudici G, Ribaldone DG, Astegiano M, Saracco GM, Pellicano R. Eosinophilic colitis: clinical review and 2020 update. Minerva Gastroenterol Dietol 2020;66:157-63.
  63. Xu Y, Xiong L, Li Y, Jiang X, Xiong Z. Diagnostic methods and drug therapies in patients with ischemic colitis. Int J Colorectal Dis 2021;36:47-56.